Case Of Unilateral Hearing Loss Research Articles

Segmental facial infantile haemangiomas in the era of propranolol: evaluation at 6 years of age.

The long-term evolution of children with segmental facial infantile haemangioma (SFIH) treated with propranolol remains unstudied. The objective of this study was to evaluate the neurodevelopmental features of children with SFIH treated with propranolol at 6 years of age. This retrospective case series study was conducted from January 2008 to June 2020 using data from medical files, patient examinations and appointments spanning 6 years. To be included, patients should present SFIH and have previously received propranolol. A complete physical examination, magnetic resonance imaging (MRI) of the head, echocardiography and ophthalmologic examination should have been performed. Neurodevelopmental features were divided into cognition, audition, vision, orality, motor skills and the occurrence of new symptoms. Thirty children with SFIH were included. Of these, 11 presented criteria of PHACES. Evaluation of neurodevelopmental features of the children at 6 years of age showed learning difficulties in one case but grade skipping in three cases. There were six cases of unilateral hearing loss that had not been diagnosed at birth, two of oral difficulties and one of minor hypotonia. Early headache was primarily reported as the main new outcome. All children were treated with propranolol, with three following oral steroid therapy. No severe adverse effects were reported. The median length of treatment with propranolol was 16 months, and the median age at treatment cessation was 21 months. Analysis based on segment implication showed the median length of treatment to vary from 12 months (if S3 was spared) to 25 months (if at least S3 was involved). Vascular laser therapy was used in 16 patients (53.3%) and surgery in four. In this case series, children with SFIH, including patients with PHACES criteria, presented a good tolerance of propranolol, as well as encouraged neurodevelopmental data. Segmental implication appears to have a significant impact on treatment duration and associated complications.

Primary Eustachian Tube Tuberculosis

Nasopharyngeal tuberculosis is a rare occurrence, and primarily involves the proximal part of the Eustachian tube. Mechanical obstruction of the Eustachian tube will affect the pressure discrepancy between the middle ear and the external atmosphere, leading to aural fullness, unilateral hearing disturbance, and otitis media. These conditions can be overlooked or mistakenly diagnosed as ear pathology. We report a case of unilateral hearing loss and tinnitus in a 31-year-old healthy woman that was later confirmed to be tuberculosis of the Eustachian tube. In cases with indicators suggesting a high index of suspicion, a thorough examination of the head and neck regions is especially very important. Once it has been diagnosed, Eustachian tuberculosis can be successfully treated with anti-tuberculosis medications.

Cochlear Implants in Patients with Fluctuant or Progressive Hearing Loss on the Better Ear.

Introduction Cochlear implants have been proposed for cases of unilateral hearing loss, especially in patients with tinnitus impairment. Several studies have shown that they result in definite improvement of sound localization and speech understanding, both in quiet and noisy environments. On the other hand, there are few references regarding cochlear implants in patients whose better ears present hearing loss. Objective To report the audiological outcomes of three patients with unilateral deafness, in whom the better ears presented hearing losses, submitted to cochlear implants. Methods Three patients with unilateral profound hearing loss underwent a cochlear implant performed by the same surgeon. Results The patients' data are presented in detail. Conclusion The indications for cochlear implants are becoming more diverse with the expansion of clinical experience and the observation that they definitely help patients with special hearing problems.

Sensorineural Hearing Loss Caused by Carbon Monoxide Poisoning―A Case of Unilateral Hearing Loss with an Arachnoid Cyst―

Sensorineural Hearing Loss Caused by Carbon Monoxide Poisoning―A Case of Unilateral Hearing Loss with an Arachnoid Cyst―

A case of bilateral enlarged vestibular aqueducts and unilateral hearing loss at birth

Screening of newborn hearing is nowadays widespread, and as many as 3.4% of all screened infants are found to have unilateral hearing loss. However, we, as clinicians and parents, usually dismiss the severity of unilateral hearing loss in pediatric patients. Recently, we experienced the case of unilateral hearing loss since birth in a 2-year-old girl who was finally found to have bilateral enlarged vestibular aqueducts when the disorder progressed to bilateral hearing loss. Proper evaluation of the cause of hearing loss, including imaging studies of the inner ear, and consecutive hearing evaluations should be mandatory in children with unilateral sensorineural hearing loss, due to the possibility of progression of hearing loss bilaterally.

人工内耳の適応に関する考察

Cochlear implant surgery is used for patients with “profound hearing loss who cannot use hearing aids.” The indications were initially limited to “adults only” but were subequently expanded to include children. In 1998, The Oto-Rhino-Laryngological Society of Japan, Inc. a published cochlear implantation adaptation guideline; the guideline was revised in 2006. Recently, the numbers of surgical patients who do not meet the Japanese Society of Otolaryngology’s criteria, such as pediatric patients below the age limit, patients requiring bilateral cochlear implants, cases of unilateral hearing loss and cases of multiple disabilities and central hearing loss cases have been increasing. In this paper, the indications for cochlear implants have been revised.

Acute Ototoxicity from a Single Infusion of Oxaliplatin

Ototoxicity secondary to the administration of the chemotherapeutic agent oxaliplatin is uncommon. We report a case of unilateral hearing loss that occurred immediately after the infusion of a single dose of oxaliplatin in a 70-year-old woman who was undergoing postoperative chemotherapy for rectal adenocarcinoma. To the best of our knowledge, no such case has been previously reported in the literature. The hearing loss in our patient was severe enough to limit her daily activities, and she experienced only minimal improvement during the next 2 years of follow-up.

Hearing screening and diagnostic evaluation of children with unilateral and mild bilateral hearing loss.

More than 90% of newborns in the United States are now being screened for hearing loss. A large fraction of cases of unilateral hearing loss and mild bilateral hearing loss are not currently identified through newborn hearing screening. This is of concern because a preponderance of research has demonstrated that unilateral hearing loss and mild bilateral hearing loss can lead to developmental delays and educational problems for some children. To help address this probable underidentification of unilateral hearing loss and mild bilateral hearing loss among infants and children, the Centers for Disease Control and Prevention Early Hearing Detection and Intervention program and the Marion Downs Hearing Center convened a workshop in Breckenridge, Colorado, in July 2005. During this workshop, several issues related to screening and diagnosing unilateral hearing loss and mild bilateral hearing loss were identified, as well as recommendations for future research in this area. Issues identified included the lack of standardized definitions for permanent unilateral hearing loss and mild bilateral hearing loss; the use of screening protocols that are primarily designed to identify bilateral and unilateral hearing losses of a moderate degree or greater (eg, above 40 dB); calibration of screening equipment; availability of facilities that can provide the full range of audiologic, diagnostic, and management services to this pediatric population; and an overall lack of awareness by many professionals and families about the potential effect of unilateral hearing loss and mild bilateral hearing loss. Suggestions for future research, such as identifying ways to improve the identification of cases of unilateral hearing loss and mild bilateral hearing loss, were also discussed.